Translational Sciences
Bridging the gap between preclinical findings and clinical outcomes through biomarker strategy, PK/PD modeling, and translational medicine.
Key Capabilities
- Translational biomarker strategy and development
- PK/PD modeling and simulation
- Preclinical-to-clinical dose translation
- Patient stratification and companion diagnostic strategy
- Mechanism of action studies and proof-of-biology
- Translational pharmacology program design
- Biomarker assay development and validation
Our Approach
Translational sciences is the bridge between preclinical research and clinical success. Bionavigen helps clients develop robust translational strategies that increase the probability of clinical success by ensuring that preclinical findings are predictive of clinical outcomes.
Our team has deep expertise in PK/PD modeling, biomarker development, and translational pharmacology. We help clients design studies that generate mechanistic insights and support go/no-go decisions.
We work closely with clinical and regulatory teams to ensure that translational data packages are compelling and support regulatory submissions and clinical development decisions.